Drug intelligence / Profile preview

Aliaxin SR

Development stage: Unknown
Lead developer: IBSA Derma
Administration: Intradermal, Subcutaneous

Overview

Aliaxin SR (Shape & Restore) is a hyaluronic acid-based dermal filler developed by IBSA. It is part of the Aliaxin product line, which utilizes Hydrolift Action to restore skin hydration, elasticity, and tone. Aliaxin SR is specifically formulated with a combination of cross-linked hyaluronic acid (22.5 mg/ml) and natural hyaluronic acid (2.5 mg/ml) to address facial sagging and volume defects. It is intended for injection into the medium to deep dermis or superficial subcutis to provide contouring and restoration of facial shapes. The product is designed to counteract the reduction of hyaluronic acid in the skin, providing both structural support and hydration.

Brand names: Aliaxin SRAliaxin
Other names: Aliaxin Shape & Restore

Beyond the preview

Go deeper on Aliaxin SR.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aliaxin SR.

Explore the full profile